Effectiveness of an organized colorectal cancer screening program on increasing adherence in asymptomatic average-risk Canadians

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Charters, Thomas J ^a   Strumpf, Erin C ^a   Sewitch, Maida J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Canada; Colorectal neoplasms diagnosis; Endoscopy; Fecal occult blood test; Mass screening; Ontario; Program evaluation

Indexed keywords

AGED; ARTICLE; CANADA; COLONOSCOPY; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; FEMALE; HEALTH PROMOTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PROGRAM EVALUATION; STATISTICS;

AGED; CANADA; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; ONTARIO; PATIENT COMPLIANCE; PROGRAM EVALUATION;

EID: 84886390198     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-449     Document Type: Article

References (51)

1. Canadian Cancer Society's Advisory Committee on Cancer Statistics, Canadian Cancer Statistics 2013 Toronto: Canadian Cancer Society 2013
2. Cancer Care Ontario, Insight on Cancer: News and Information on Colorectal Cancer and Screening in Ontario, vol. 7 Toronto: Canadian Cancer Society (Ontario Division) 2008
3. Cancer Care Manitoba, Cancer in Manitoba Incidence and Mortality 2007 Annual Statistical Report Winnipeg: Manitoba Epidemiology and Cancer Registry 2010
4. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Ries LAG, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, Edwards BK, Cancer 2000 88 10 2398 2424 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I 10820364 (Pubitemid 30247142)
5. Lifetime costs of colon and rectal cancer management in Canada. Maroun J, Ng E, Berthelot JM, Le Petit C, Dahrouge S, Flanagan WM, Walker H, Evans WK, Chronic Dis Can 2003 24 4 91 101 14733758 (Pubitemid 38155547)
6. Organized colorectal cancer screening in integrated health care systems. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C, Epidemiol Rev 2011 33 1 101 110 10.1093/epirev/mxr007 21709143
7. Recommendations for population-based colorectal cancer screening. National Committee on Colorectal Cancer Screening, 2002 [ http://www.phac-aspc. gc.ca/publicat/ncccs-cndcc/ccsrec-eng.php ]
8. Colorectal cancer screening: recommendation statement from the Canadian task force on preventive health care. Canadian Task Force on Preventive Health Care, CMAJ 2001 165 2 206 208 11501466
9. Canadian association of gastroenterology and the Canadian digestive health foundation: guidelines on colon cancer screening. Leddin D, Hunt R, Champion M, Cockeram A, Flook N, Gould M, Kim Y-I, Love J, Morgan D, Natsheh S, et al. Can J Gastroenterol 2004 18 2 93 99 14997217 (Pubitemid 38418034)
10. Canadian association of gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Leddin DJ, Enns R, Hilsden R, Plourde V, Rabeneck L, Sadowski DC, Singh H, Can J Gastroenterol 2010 24 12 705 714 21165377
11. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L, Am J Gastroenterol 2008 103 6 1541 1549 10.1111/j.1572-0241. 2008.01875.x 18479499 (Pubitemid 351813919)
12. Cost-effectiveness analyses of colorectal cancer screening. Pignone M, Saha S, Hoerger T, Mandelblatt J, Ann Intern Med 2002 137 2 96 104 10.7326/0003-4819-137-2-200207160-00007 12118964
13. Cost-effectiveness of colorectal cancer screening. Lansdorp-Vogelaar I, Knudsen AB, Brenner H, Epidemiol Rev 2011 33 1 88 100 10.1093/epirev/mxr004 21633092
14. Potential impact of population-based colorectal cancer screening in Canada. Flanagan WM, Le Petit C, Berthelot J-M, White KJ, Coombs BA, Jones-McLean E, Chronic Dis Can 2003 24 4 81 88 14733756 (Pubitemid 38155545)
15. The cost-effectiveness of screening for colorectal cancer. Telford JJ, Levy AR, Sambrook JC, Zou D, Enns RA, CMAJ 2010 182 12 1307 1313 10.1503/cmaj.090845 20624866
16. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. preventive services task force. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM, Ann Intern Med 2008 149 9 659 669 10.7326/0003-4819-149-9-200811040-00244 18838717
17. Romanow RJ, Building on Values: the Future of Health Care in Canada Ottawa: Commission on the Future of Health Care in Canada Privy Council. 2002
18. Adherence to colorectal cancer screening guidelines in Canada. Sewitch MJ, Fournier C, Ciampi A, Dyachenko A, BMC Gastroenterol 2007 7 39 10.1186/1471-230X-7-39
19. Colorectal cancer testing in Canada-2008. Wilkins K, Shields M, Health Rep 2009 20 3 21 30
20. An update on mammography use in Canada. Shields M, Wilkins K, Health Rep 2009 20 3 7 19
21. Cancer Care Ontario, Ontario FOBT Project Steering Committee: Ontario FOBT Project Final Report Toronto: Ministry of Health and Long Term Care 2006
22. Survey of colorectal cancer screening practices in a large Canadian urban centre. Mack LA, Stuart H, Temple WJ, Can J Surg 2004 47 3 189 194 15264381 (Pubitemid 39164370)
23. Cancer Care Ontario: Policy and Planning Unit; Prevention and Screening Dept, Colon Cancer Check 2008 Program Report Toronto: Cancer Care Ontario 2010
24. Phase 1 Summary of Results. ColonCheck Manitoba, 2010 [ http://www.cancercare.mb.ca/resource/File/coloncheckmb/ColonCheck-Phase-1- Summary.pdf ]
25. Alberta Health Services Board, Alberta Health Services Annual Report April 1, 2008-March 31, 2009 Alberta Health Services 2009
26. Reductions in mortality associated with intensive public reporting of hospital outcomes. Hollenbeak CS, Gorton CP, Tabak YP, Jones JL, Milstein A, Johannes RS, Am J Med Qual 2008 23 4 279 286 10.1177/1062860608318451 18658101
27. Economic evaluation of an intensified disease management system for patients with type 2 diabetes. Lairson DR, Yoon SJ, Carter PM, Greisinger AJ, Talluri KC, Aggarwal M, Wehmanen O, Dis Manag 2008 11 2 79 94 10.1089/dis.2008.1120009 18393650 (Pubitemid 351571049)
28. The association between state mandates of colorectal cancer screening coverage and colorectal cancer screening utilization among US adults aged 50 to 64 years with health insurance. Cokkinides V, Bandi P, Shah M, Virgo K, Ward E, BMC Health Serv Res 2011 11 1 19 10.1186/1472-6963-11-19
29. Statistics Canada, Canadian Community Health Survey (CCHS)- Annual Component: User Guide 2009 Microdata files Ottawa: Statistics Canada 2010
30. CCHS 2009: Data Dictionary Master File-12 Month (Rounded). Statistics Canada, 2009 [ http://www23.statcan.gc.ca:81/imdb-bmdi/pub/document/3226-D3-T9- V15-eng.pdf ]
31. Statistics Act. Statistics Canada, 2012 [ http://www.statcan.gc.ca/about- apercu/act-loi-eng.htm ]
32. Tri-Council Policy Statement: ethical conduct for research involving humans. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada, 2010 19
33. Angrist JD, Pischke JS, Mostly Harmless Econometrics: an Empiricist's Companion Princeton: Princeton University Press 2009
34. How effective are colorectal cancer screening programs at increasing the rate of screening in asymptomatic average-risk groups in Canada? Charters TJ, MSc Thesis Montreal: McGill University 2011
35. Combining cycles of the Canadian community health survey. Thomas S, Wannell B, Health Rep 2009 20 1 53 58
36. Korn EL, Graubard BI, Analysis of Health Surveys New York: John Wiley & Sons, Inc 1999
37. Variance estimation for complex surveys using replication techniques. Rust KF, Rao JNK, Stat Methods Med Res 1996 5 283 310 10.1177/096228029600500305 8931197 (Pubitemid 126559356)
38. StataCorp, Stata: release 11 Texas: StataCorp LP. College Station 2009
39. Medicaid's effect on single women's labor supply: evidence from the introduction of Medicaid. Strumpf E, J Health Econ 2011 30 3 531 548 10.1016/j.jhealeco.2011.02.002 21507494
40. Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project. Paszat L, Rabeneck L, Kiefer L, Mai V, Ritvo P, Sullivan T, Can J Gastroenterol 2007 21 6 379 382 17571172 (Pubitemid 47162255)
41. Wait times for colonoscopy after a positive fecal occult blood test (FOBT). Cancer Care Ontario, 2009 [ https://www.cancercare.on.ca/cms/one.aspx? pageId=41101 ]
42. Access to specialist gastroenterology care in Canada: the practice audit in gastroenterology (PAGE) wait times program. Armstrong D, Barkun ANG, Chen Y, Daniels S, Hollingworth R, Hunt RH, Leddin D, Can J Gastroenterol 2008 22 2 155 160 18299734 (Pubitemid 351566111)
43. Cancer Care Ontario, ColonCancerCheck Update: Spring 2010 Toronto: Ministry of Health and Long Term Care 2010
44. How much should we trust differences-in-differences estimates?*. Bertrand M, Duflo E, Mullainathan S, Q J Econ 2004 119 1 249 275 10.1162/003355304772839588 (Pubitemid 38361206)
45. Accuracy of self-reported cancer-screening histories: a meta-analysis. Rauscher GH, Johnson TP, Cho YI, Walk JA, Cancer Epidemiol Biomarkers Prev 2008 17 4 748 757 10.1158/1055-9965.EPI-07-2629 18381468 (Pubitemid 351536402)
46. Screening & Diagnostics > A guide to screening tests. Colorectal Cancer Association of Canada, 2012 [ http://www.colorectal-cancer.ca/en/ screening/screening-tests/#ii ]
47. Overview of the national cancer screening programme and the cancer screening status in Korea. Kim Y, Jun JK, Choi KS, Lee HY, Park EC, Asian Pac J Cancer Prev 2011 12 725 730 21627372
48. Initial impact of Australia's national bowel cancer screening program. Ananda SS, McLaughlin SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, Steel MCA, Jones IT, Hastie IA, Rieger NA, Med J Aust 2009 191 7 378 381 19807627
49. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK, PLoS Med 2012 9 12 1001352 10.1371/journal.pmed.1001352 23226108
50. Screening for colorectal cancer: a targeted, updated systematic review for the US preventive services task force. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R, Ann Intern Med 2008 149 9 638 658 10.7326/0003-4819-149-9-200811040- 00245 18838718
51. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Van Rossum LG, Van Rijn AF, Laheij RJ, Van Oijen MG, Fockens P, Van Krieken HH, Verbeek AL, Jansen JB, Dekker E, Gastroenterology 2008 135 1 82 90 10.1053/j.gastro.2008.03.040 18482589 (Pubitemid 351899018)